Ananda Developments - Endometriosis Trial Drug Supply Agreement Signed
RNS
Latest announcements
Announcement summary
Ananda Developments - Endometriosis Trial Drug Supply Agreement Signed
This agreement is a critical step on the road to regulatory approval for MRX1 as a medicine for endometriosis and its purpose is to govern the supply of MRX1 in to the trial and the flow of IP back to the Company from the trial.
Ask a question
Your question will be sent privately to Ananda Pharma. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Ananda Pharma a question about this announcement.